Comparative Pharmacology
Head-to-head clinical analysis: BUTALBITAL ACETAMINOPHEN CAFFEINE AND CODEINE PHOSPHATE versus SODIUM PENTOBARBITAL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BUTALBITAL ACETAMINOPHEN CAFFEINE AND CODEINE PHOSPHATE versus SODIUM PENTOBARBITAL.
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE vs SODIUM PENTOBARBITAL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Butalbital is a barbiturate that enhances GABA-A receptor activity, producing sedation; acetaminophen inhibits cyclooxygenase (COX) enzymes centrally, reducing pain and fever; caffeine is a nonselective adenosine receptor antagonist, causing vasoconstriction and central nervous system stimulation; codeine is an opioid agonist at mu-opioid receptors, providing analgesia and antitussive effects.
Barbiturate that enhances GABA-A receptor activity, prolonging chloride channel opening and increasing inhibitory neurotransmission. At high doses, it acts as a GABA mimetic and depresses neuronal excitability.
1-2 capsules orally every 4 hours as needed for pain, not exceeding 6 capsules per day. Each capsule contains butalbital 50 mg, acetaminophen 300 mg, caffeine 40 mg, and codeine phosphate 30 mg.
IV: 100-150 mg administered over 1-2 minutes for induction of anesthesia; for seizure control, 100 mg IV every 5-10 minutes up to 500 mg. For maintenance of anesthesia, 50 mg IV as needed every 15-30 minutes. IM: 150-200 mg for preoperative sedation.
None Documented
None Documented
Butalbital: ~35 hours (range 30-50 h), long-acting barbiturate; Acetaminophen: ~2-3 hours; Caffeine: ~3-5 hours in adults; Codeine: ~2.5-3.5 hours; note that codeine's active metabolite morphine has half-life ~2-3 h, and renal impairment prolongs half-life of butalbital and codeine.
15-50 hours (dose-dependent; prolonged in hepatic impairment).
Butalbital: ~60-70% renal as unchanged drug and metabolites; Acetaminophen: ~90-100% renal within 24 hours (2-5% unchanged, rest as glucuronide and sulfate conjugates); Caffeine: ~1-2% renal unchanged, rest metabolized; Codeine: ~90% renal (10% unchanged, 40% as codeine-6-glucuronide, rest as morphine and norcodeine metabolites). Biliary/fecal excretion minimal for all components.
Renal (25-50% unchanged); hepatic metabolism to inactive metabolites; fecal <5%.
Category D/X
Category D/X
Barbiturate + Analgesic
Barbiturate